F.D.A.

Organization
Mentions
5
Relationships
0
Events
0
Documents
2
Also known as:
Food and Drug Administration (F.D.A.)

Relationship Network

Loading... nodes
Interactive Network: Click nodes or edges to highlight connections and view details with action buttons. Drag nodes to reposition. Node size indicates connection count. Line color shows relationship strength: red (8-10), orange (6-7), yellow (4-5), gray (weak). Use legend and help buttons in the graph for more guidance.
No relationships found for this entity.
No events found for this entity.

HOUSE_OVERSIGHT_029929.jpg

This document is a page from a December 12, 2011 issue of The New Yorker, stamped with 'HOUSE_OVERSIGHT_029929', indicating it is part of a Congressional investigation. The text is an article discussing the medical efficacy and scientific definition of the 'placebo effect,' featuring interviews with Robert Temple of the FDA and referencing studies by Danish researchers. While the content is scientific, its inclusion in the oversight file suggests it may be relevant to inquiries regarding medical funding, research practices, or specific individuals (like Epstein) who may have had interests in these scientific fields.

Magazine article (the new yorker) / legal discovery document
2025-11-19

HOUSE_OVERSIGHT_028420.jpg

The document is JSON code describing an article about the pharmaceutical company Celgene. The article alleges that Celgene used a federal safety program (REMS) to block generic competition for its drugs, Revlimid and Thalomid, leading to lawsuits from companies like Mylan. The text also mentions a patient paying high costs and a professor criticizing Celgene's actions.

Document metadata in json format
2025-11-19
Total Received
$0.00
0 transactions
Total Paid
$0.00
0 transactions
Net Flow
$0.00
0 total transactions
No financial transactions found for this entity. Entity linking may need to be improved.
As Sender
0
As Recipient
0
Total
0
No communications found for this entity. Entity linking may need to be improved.

Discussion 0

Sign in to join the discussion

No comments yet

Be the first to share your thoughts on this epstein entity